Strategic partnerships CRG collaborates with academia, government funders, and industry players, suggesting opportunities for collaborative research programs, sponsored projects, and joint grants with biotech firms and pharma.

Spin-off ecosystem CRG has a track record of spin-offs (e.g., Orikine Bio) and biotech entrepreneurship activities (BioBusiness School), signaling potential for translational partnerships, co-development deals, and early-access programs for novel therapies.

Tech & data leverage With a tech stack including Oracle ERP, Power BI, Elasticsearch and collaboration tools, CRG is positioned to benefit from data-driven research services, analytics, and digital infrastructure offerings for life sciences partners.

Funding & programs Significant public funding and multinational collaborations, plus a funded international PhD program, create doors for sponsored research agreements, student-inclusive collaborations, and capacity-building projects with industry sponsors.

Clinical and translational tie-ins CRG’s engagement with clinical-stage entities (evidenced by joint presentations and partnerships) indicates openness to translational research, enabling opportunities in biomarkers, diagnostic tools, and CNS-related therapeutic development.